In a report released today, Andy Hargreaves from KeyBanc maintained a Buy rating on Cardlytics Inc (NASDAQ: CDLX), with a price target of $28. The company’s shares closed yesterday at $20.24.
Hargreaves has an average return of 10.0% when recommending Cardlytics Inc.
According to TipRanks.com, Hargreaves is ranked #92 out of 4857 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Cardlytics Inc with a $27.50 average price target, implying a 35.9% upside from current levels. In a report issued on August 13, SunTrust Robinson also maintained a Buy rating on the stock with a $27 price target.
.
See today’s analyst top recommended stocks >>
Based on Cardlytics Inc’s latest earnings release for the quarter ending June 30, the company reported a quarterly GAAP net loss of $13.05 million. In comparison, last year the company had a GAAP net loss of $648K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel.
